https://clinicaltrials.gov/ct2/show/NCT02993328
There's some incentive.
Column 1 Column 2 0 Estimated Enrollment: 72 1 Anticipated Study Start Date: December 2017 2 Estimated Study Completion Date: June 2018 3 Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)
- Forums
- ASX - By Stock
- QIN
- Santalis FDA phase 2 details
Santalis FDA phase 2 details
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online